Theodore L. Roth

13.2k citations

28 papers · 3.6k indexed · 4 hit papers · h-index 20

Molecular Biology top 5%
Neurology top 0.5%
Immunology top 5%
Oncology top 5%
Neurology top 2%

Co-authors: Dorian B. McGavern Debasis Nayak Kara N. Corps Alexander Marson Tatjana Atanasijević Lawrence L. Latour Alan P. Koretsky Eric Shifrut
Topics: CRISPR and Genetic Engineering (16 papers)CAR-T cell therapy research (10 papers)Immune Cell Function and Interaction (4 papers)
Cited by: Neurology Biological Psychiatry Developmental Neuroscience
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States Japan Singapore

In The Last Decade

Theodore L. Roth

28 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microglia Development and Function

2014 849 citations Debasis Nayak, Theodore L. Roth et al. profile →
Inflammation and Neuroprotection in Traumatic Brain Injury

2015 643 citations Theodore L. Roth, Dorian B. McGavern et al. profile →
Transcranial amelioration of inflammation and cell death after brain injury

2013 467 citations Theodore L. Roth, Debasis Nayak et al. Nature profile →
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function

2018 339 citations Eric Shifrut, Julia Carnevale et al. Cell profile →

Peers

Countries citing papers authored by Theodore L. Roth

Since Specialization

Citations

This map shows the geographic impact of Theodore L. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore L. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore L. Roth more than expected).

Fields of papers citing papers by Theodore L. Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore L. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore L. Roth. The network helps show where Theodore L. Roth may publish in the future.

Co-authorship network of co-authors of Theodore L. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore L. Roth. A scholar is included among the top collaborators of Theodore L. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore L. Roth. Theodore L. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-viral intron knock-ins for targeted gene integration into human T cells and for T-cell selection 2025 ·Nature Biomedical Engineering ·Theodore L. Roth,(unknown),(unknown),(unknown),(unknown),Ansuman T. Satpathy	2
2	Site-specific DNA insertion into the human genome with engineered recombinases 2025 ·Nature Biotechnology ·Alison Fanton,(unknown),Jade Martins,(unknown),Laine Goudy,(unknown),Matthew G. Durrant,(unknown),(unknown),April Pawluk,Silvana Konermann,Alexander Marson,Luke A. Gilbert,Theodore L. Roth,Patrick D. Hsu	1
3	XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment 2021 ·Science Advances ·Youjin Lee,Derek Bogdanoff,Yutong Wang,George C. Hartoularos,Jonathan M. Woo,Cody T. Mowery,Hunter Nisonoff,David Lee,Yang Sun,James Lee,Sadaf Mehdizadeh,Joshua Cantlon,Eric Shifrut,(unknown),Theodore L. Roth,Yun S. Song,Alexander Marson,Eric D. Chow,Chun Ye	83
4	The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28 2021 ·Frontiers in Immunology ·Yannick D. Müller,Duy Nguyen,Leonardo M. R. Ferreira,Patrick Ho,Caroline Raffin,(unknown),(unknown),Theodore L. Roth,Justin Eyquem,Frédéric Van Gool,Alexander Marson,Laurent Perez,James A. Wells,Jeffrey A. Bluestone,Qizhi Tang	85
5	Robust T cell activation requires an eIF3-driven burst in T cell receptor translation 2021 ·eLife ·(unknown),Lucas Ferguson,(unknown),Benjamin E. Smith,Ryan Apathy,Theodore L. Roth,Franziska Blaeschke,Marek Kudła,Alexander Marson,Nicholas T. Ingolia,J.H.D. Cate	16
6	Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies 2020 ·Cell ·Theodore L. Roth,P. Jonathan Li,Franziska Blaeschke,Jasper F. Nies,Ryan Apathy,Cody T. Mowery,Ruby Yu,Michelle Nguyen,Youjin Lee,(unknown),Joseph Hiatt,David Wu,David N. Nguyen,Daniel B. Goodman,Jeffrey A. Bluestone,Chun Ye,Kole T. Roybal,Eric Shifrut,Alexander Marson	130
7	Helios enhances the preferential differentiation of human fetal CD4 ⁺ naïve T cells into regulatory T cells 2019 ·Science Immunology ·Melissa Ng,Theodore L. Roth,Ventura F. Mendoza,Alexander Marson,Trevor D. Burt	34
8	Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function 2019 ·Nature Biomedical Engineering ·Kilian Schober,Thomas Müller,(unknown),Simon Grassmann,Manuel Effenberger,Mateusz P. Poltorak,Christian Stemberger,Kathrin Schumann,Theodore L. Roth,Alexander Marson,Dirk H. Busch	115
9	Large dataset enables prediction of repair after CRISPR–Cas9 editing in primary T cells 2019 ·Nature Biotechnology ·Ryan T. Leenay,Amirali Aghazadeh,Joseph Hiatt,David Tse,Theodore L. Roth,Ryan Apathy,Eric Shifrut,Judd F. Hultquist,Nevan J. Krogan,Zhenqin Wu,(unknown),Hera Canaj,Manuel D. Leonetti,Alexander Marson,Andrew P. May,James Zou	82
10	Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency 2019 ·Nature Biotechnology ·David N. Nguyen,Theodore L. Roth,P. Jonathan Li,Peixin Amy Chen,Ryan Apathy,Murad R. Mamedov,Linda T. Vo,Victoria Tobin,Daniel B. Goodman,Eric Shifrut,Jeffrey A. Bluestone,Jennifer M. Puck,Francis C. Szoka,Alexander Marson	194
11	Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms 2018 ·Journal of Visualized Experiments ·Behnom Farboud,Erin Jarvis,Theodore L. Roth,Jiyung Shin,Jacob E. Corn,Alexander Marson,Barbara J Meyer,Nipam H. Patel,Megan L. Hochstrasser	12
12	Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms 2018 ·Journal of Visualized Experiments ·Behnom Farboud,Erin Jarvis,Theodore L. Roth,Jiyung Shin,Jacob E. Corn,Alexander Marson,Barbara J Meyer,Nipam H. Patel,Megan L. Hochstrasser	34
13	CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions 2018 ·Nature Protocols ·Judd F. Hultquist,Joseph Hiatt,Kathrin Schumann,Michael McGregor,Theodore L. Roth,Paige Haas,Jennifer A. Doudna,Alexander Marson,Nevan J. Krogan	78
14	Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Functionbreakdown → 2018 ·Cell ·Eric Shifrut,Julia Carnevale,Victoria Tobin,Theodore L. Roth,Jonathan M. Woo,(unknown),P. Jonathan Li,Morgan E. Diolaiti,Alan Ashworth,Alexander Marson	339
15	Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins 2018 ·Journal of Immunological Methods ·(unknown),Theodore L. Roth,Yuriy Baglaenko,(unknown),Patrick M. Brauer,Juan Carlos Zúñiga‐Pflücker,Kristina W. Rosbe,Joan Wither,Alexander Marson,Christopher D.C. Allen	39
16	Light-activated cell identification and sorting (LACIS) for selection of edited clones on a nanofluidic device 2018 ·Communications Biology ·(unknown),Theodore L. Roth,Hayley M. Bennett,Magali Soumillon,(unknown),Joseph Hiatt,Kevin Chapman,Alexander Marson,Grégory Lavieu	39
17	Migratory and adhesive cues controlling innate-like lymphocyte surveillance of the pathogen-exposed surface of the lymph node 2016 ·eLife ·Yang Zhang,Theodore L. Roth,Elizabeth Gray,Hsin Chen,Lauren B. Rodda,(unknown),Patrick Ventura,Saul Villeda,Paul R. Crocker,Jason G. Cyster	72
18	A Rapid and Simple Method for DNA Engineering Using Cycled Ligation Assembly 2014 ·PLoS ONE ·Theodore L. Roth,Ljiljana Milenković,Matthew P. Scott	17
19	Type I Interferon Programs Innate Myeloid Dynamics and Gene Expression in the Virally Infected Nervous System 2013 ·PLoS Pathogens ·Debasis Nayak,Kory Johnson,Sara Heydari,Theodore L. Roth,Bernd H. Zinselmeyer,Dorian B. McGavern	48
20	Transcranial amelioration of inflammation and cell death after brain injurybreakdown → 2013 ·Nature ·Theodore L. Roth,Debasis Nayak,Tatjana Atanasijević,Alan P. Koretsky,Lawrence L. Latour,Dorian B. McGavern	467

About Theodore L. Roth

Theodore L. Roth is a scholar working on Neurology, Immunology and Oncology, having authored 28 papers that have together received 3.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (16 papers), CAR-T cell therapy research (10 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Neurology (957 citations), Biological Psychiatry (131 citations) and Developmental Neuroscience (207 citations). Theodore L. Roth has collaborated with scholars based in United States, Japan and Singapore. Frequent co-authors include Dorian B. McGavern, Debasis Nayak, Kara N. Corps, Alexander Marson, Tatjana Atanasijević, Lawrence L. Latour, Alan P. Koretsky, Eric Shifrut, P. Jonathan Li and Victoria Tobin. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact